isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder

RxCUI: 1551412
RxNorm name: isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder
Term type: SCD
Status: Active
Updated: 2026-10-13 14:25:38

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 112014
Active start: 112014
Multiple ingredient: YES
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
tetracaine hydrochloride	0.005 MG / 1 MG	tetracaine	tetracaine hydrochloride
isoflupredone acetate	0.001 MG / 1 MG	isoflupredone	isoflupredone acetate
neomycin sulfate	0.0035 MG / 1 MG	neomycin	neomycin

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Powder	317009

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
tetracaine	10391
isoflupredone	1546449
neomycin	7299

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
RXNAV_STR	isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder	1	NAMES
RxNorm Name	isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder	1	NAMES
RxNorm Synonym	isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG per 1 GM Topical Powder	1	NAMES
TTY	SCD	1	ATTRIBUTES
RxCUI	1551412	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
5de35de9-7db4-49da-be31-6788fe8558e4	isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine HCl 0.005 MG/MG Topical Powder [PSN] · isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder [SCD] · isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG per 1 GM Topical Powder [SY]	3	5	Neo-Predef ® with Tetracaine Powder	20200528

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	D04AB	Anesthetics for topical use	ATC1-4		tetracaine
ATC	A07AA	Antibiotics	ATC1-4		neomycin
ATC	S01AA	Antibiotics	ATC1-4		neomycin
ATC	R02AB	Antibiotics	ATC1-4		neomycin
ATC	B05CA	Antiinfectives	ATC1-4		neomycin
ATC	S03AA	Antiinfectives	ATC1-4		neomycin
ATC	S02AA	Antiinfectives	ATC1-4		neomycin
ATC	A01AB	Antiinfectives and antiseptics for local oral treatment	ATC1-4		neomycin
ATC	N01BA	Esters of aminobenzoic acid	ATC1-4		tetracaine
ATC	C05AD	Local anesthetics	ATC1-4		tetracaine
ATC	S01HA	Local anesthetics	ATC1-4		tetracaine
ATC	J01GB	Other aminoglycosides	ATC1-4		neomycin
ATC	D06AX	Other antibiotics for topical use	ATC1-4		neomycin
FDASPL	D000617	Aminoglycosides	CHEM	has_chemical_structure	neomycin
FDASPL	D004952	Esters	CHEM	has_chemical_structure	tetracaine
FDASPL	N0000175477	Aminoglycoside Antibacterial	EPC	has_epc	neomycin
FDASPL	N0000175683	Ester Local Anesthetic	EPC	has_epc	tetracaine
FDASPL	N0000175976	Local Anesthesia	PE	has_pe	tetracaine
MEDRT	D005477	Fluprednisolone	CHEM	has_ingredient	isoflupredone acetate
MEDRT	D005477	Fluprednisolone	CHEM	has_ingredient	isoflupredone
MEDRT	D009355	Neomycin	CHEM	has_ingredient	neomycin
MEDRT	D013748	Tetracaine	CHEM	has_ingredient	tetracaine
MEDRT	D001424	Bacterial Infections	DISEASE	may_prevent	neomycin
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	tetracaine hydrochloride
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	tetracaine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	neomycin
MEDRT	D004927	Escherichia coli Infections	DISEASE	may_treat	neomycin
MEDRT	D006501	Hepatic Encephalopathy	DISEASE	may_treat	neomycin
MEDRT	D015212	Inflammatory Bowel Diseases	DISEASE	ci_with	neomycin
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	neomycin
MEDRT	D010146	Pain	DISEASE	may_treat	tetracaine
MEDRT	D010146	Pain	DISEASE	may_prevent	tetracaine
MEDRT	D010146	Pain	DISEASE	may_prevent	tetracaine hydrochloride
MEDRT	D010146	Pain	DISEASE	may_treat	tetracaine hydrochloride
MEDRT	D017192	Skin Diseases, Bacterial	DISEASE	may_treat	neomycin
MEDRT	N0000000150	Protein Synthesis Inhibitors	MOA	has_moa	neomycin
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	tetracaine
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	tetracaine hydrochloride
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	neomycin
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	tetracaine
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	tetracaine hydrochloride
MEDRT	N0000175976	Local Anesthesia	PE	has_pe	tetracaine
MEDRT	N0000175976	Local Anesthesia	PE	has_pe	tetracaine hydrochloride

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Neo-Predef	rxnav_allrelated
DF	DF	Topical Powder	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
IN	IN	isoflupredone	rxnav_allrelated
IN	IN	neomycin	rxnav_allrelated
IN	IN	tetracaine	rxnav_allrelated
MIN	MIN	isoflupredone / neomycin / tetracaine	rxnav_allrelated
PIN	PIN	isoflupredone acetate	rxnav_allrelated
PIN	PIN	tetracaine hydrochloride	rxnav_allrelated
SBD	SBD	isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder [Neo-Predef]	rxnav_allrelated
SBDC	SBDC	isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG [Neo-Predef]	rxnav_allrelated
SBDF	SBDF	isoflupredone / neomycin / tetracaine Topical Powder [Neo-Predef]	rxnav_allrelated
SBDFP	SBDFP	isoflupredone acetate / neomycin / tetracaine hydrochloride Topical Powder [Neo-Predef]	rxnav_allrelated
SBDG	SBDG	Neo-Predef Topical Product	rxnav_allrelated
SCD	SCD	isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder	rxnav_allrelated
SCDC	SCDC	isoflupredone acetate 0.001 MG/MG	rxnav_allrelated
SCDC	SCDC	neomycin 0.0035 MG/MG	rxnav_allrelated
SCDC	SCDC	tetracaine hydrochloride 0.005 MG/MG	rxnav_allrelated
SCDF	SCDF	isoflupredone / neomycin / tetracaine Topical Powder	rxnav_allrelated
SCDFP	SCDFP	isoflupredone acetate / neomycin / tetracaine hydrochloride Topical Powder	rxnav_allrelated
SCDG	SCDG	isoflupredone / neomycin / tetracaine Topical Product	rxnav_allrelated
SCDGP	SCDGP	isoflupredone acetate / neomycin / tetracaine hydrochloride Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	RXNAV_VET_DRUG	US
ATTRIBUTES	VET_DRUG	US
NAMES	Prescribable Synonym	isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine HCl 0.005 MG/MG Topical Powder